Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

Europe - FRA:6D81 - US26614N1028 - Common Stock

64.42 EUR
-1.11 (-1.69%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

5

Overall 6D81 gets a fundamental rating of 5 out of 10. We evaluated 6D81 against 69 industry peers in the Chemicals industry. 6D81 has an average financial health and profitability rating. 6D81 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

6D81 had positive earnings in the past year.
6D81 had a positive operating cash flow in the past year.
Of the past 5 years 6D81 4 years were profitable.
In the past 5 years 6D81 always reported a positive cash flow from operatings.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

6D81 has a Return On Assets (-0.53%) which is comparable to the rest of the industry.
With a Return On Equity value of -0.84%, 6D81 perfoms like the industry average, outperforming 42.03% of the companies in the same industry.
6D81 has a Return On Invested Capital of 4.27%. This is in the better half of the industry: 6D81 outperforms 60.87% of its industry peers.
6D81 had an Average Return On Invested Capital over the past 3 years of 3.52%. This is below the industry average of 7.19%.
The last Return On Invested Capital (4.27%) for 6D81 is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.53%
ROE -0.84%
ROIC 4.27%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Profit Margin of 6D81 has grown nicely.
Looking at the Operating Margin, with a value of 16.47%, 6D81 belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
In the last couple of years the Operating Margin of 6D81 has grown nicely.
6D81's Gross Margin of 37.34% is in line compared to the rest of the industry. 6D81 outperforms 59.42% of its industry peers.
6D81's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.47%
PM (TTM) N/A
GM 37.34%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

6D81 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
6D81 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 6D81 has less shares outstanding
The debt/assets ratio for 6D81 has been reduced compared to a year ago.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that 6D81 is in the distress zone and has some risk of bankruptcy.
6D81 has a Altman-Z score of 1.10. This is in the lower half of the industry: 6D81 underperforms 75.36% of its industry peers.
The Debt to FCF ratio of 6D81 is 5.43, which is a neutral value as it means it would take 6D81, 5.43 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 6D81 (5.43) is better than 73.91% of its industry peers.
6D81 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
6D81's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. 6D81 outperforms 71.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.43
Altman-Z 1.1
ROIC/WACC0.51
WACC8.4%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.41 indicates that 6D81 should not have too much problems paying its short term obligations.
The Current ratio of 6D81 (1.41) is worse than 65.22% of its industry peers.
6D81 has a Quick Ratio of 1.41. This is a bad value and indicates that 6D81 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 6D81 (0.94) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.94
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

6D81 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.63%, which is quite impressive.
Measured over the past years, 6D81 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.50% on average per year.
Looking at the last year, 6D81 shows a small growth in Revenue. The Revenue has grown by 4.55% in the last year.
6D81 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.31% yearly.
EPS 1Y (TTM)25.63%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%15.46%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%2.71%

3.2 Future

6D81 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.81% yearly.
6D81 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.48% yearly.
EPS Next Y10.15%
EPS Next 2Y8.08%
EPS Next 3Y8.05%
EPS Next 5Y5.81%
Revenue Next Year2.83%
Revenue Next 2Y2.5%
Revenue Next 3Y3.15%
Revenue Next 5Y2.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.95, which indicates a correct valuation of 6D81.
68.12% of the companies in the same industry are more expensive than 6D81, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 6D81 to the average of the S&P500 Index (27.55), we can say 6D81 is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.90 indicates a correct valuation of 6D81.
6D81's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 6D81 is cheaper than 65.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.04, 6D81 is valued a bit cheaper.
Industry RankSector Rank
PE 16.95
Fwd PE 15.9
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

6D81's Enterprise Value to EBITDA ratio is in line with the industry average.
69.57% of the companies in the same industry are more expensive than 6D81, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.94
EV/EBITDA 11.31
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

6D81's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
6D81 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y8.08%
EPS Next 3Y8.05%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.02%, 6D81 has a reasonable but not impressive dividend return.
6D81's Dividend Yield is comparable with the industry average which is at 3.22.
Compared to an average S&P500 Dividend Yield of 2.43, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

6D81 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-340.72%
EPS Next 2Y8.08%
EPS Next 3Y8.05%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

DUPONT DE NEMOURS INC

FRA:6D81 (9/25/2025, 7:00:00 PM)

64.42

-1.11 (-1.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners74.6%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap26.97B
Analysts83.85
Price Target78.1 (21.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend1.28
Dividend Growth(5Y)-33.98%
DP-340.72%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.64%
Min EPS beat(2)2.3%
Max EPS beat(2)4.98%
EPS beat(4)4
Avg EPS beat(4)7.65%
Min EPS beat(4)2.3%
Max EPS beat(4)11.99%
EPS beat(8)7
Avg EPS beat(8)8.15%
EPS beat(12)10
Avg EPS beat(12)6.47%
EPS beat(16)14
Avg EPS beat(16)7.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)-2.14%
Revenue beat(4)0
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)-2.14%
Revenue beat(8)2
Avg Revenue beat(8)-2.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.72%
Revenue beat(16)3
Avg Revenue beat(16)-4.29%
PT rev (1m)2.62%
PT rev (3m)3.23%
EPS NQ rev (1m)-0.78%
EPS NQ rev (3m)1.77%
EPS NY rev (1m)-1.17%
EPS NY rev (3m)2.18%
Revenue NQ rev (1m)-1.14%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 16.95
Fwd PE 15.9
P/S 2.51
P/FCF 23.94
P/OCF 16.17
P/B 1.37
P/tB 19.06
EV/EBITDA 11.31
EPS(TTM)3.8
EY5.9%
EPS(NY)4.05
Fwd EY6.29%
FCF(TTM)2.69
FCFY4.18%
OCF(TTM)3.98
OCFY6.18%
SpS25.66
BVpS46.94
TBVpS3.38
PEG (NY)1.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.53%
ROE -0.84%
ROCE 6.55%
ROIC 4.27%
ROICexc 4.54%
ROICexgc 16%
OM 16.47%
PM (TTM) N/A
GM 37.34%
FCFM 10.49%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.43
Debt/EBITDA 1.63
Cap/Depr 53.18%
Cap/Sales 5.04%
Interest Coverage 250
Cash Conversion 59.85%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.94
Altman-Z 1.1
F-Score5
WACC8.4%
ROIC/WACC0.51
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.63%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%15.46%
EPS Next Y10.15%
EPS Next 2Y8.08%
EPS Next 3Y8.05%
EPS Next 5Y5.81%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%2.71%
Revenue Next Year2.83%
Revenue Next 2Y2.5%
Revenue Next 3Y3.15%
Revenue Next 5Y2.48%
EBIT growth 1Y20%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year30.49%
EBIT Next 3Y13.32%
EBIT Next 5Y9.33%
FCF growth 1Y373.84%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y97.48%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%